Full Press Release Details
Group Announces Strategic Acquisition of HM Management to Expand AI Application Ecosystem
China - May 2, 2025 (PRNewswire) - BGM Group Ltd. (Nasdaq: BGM) (the "Company"
or "BGM") , a leading AI technology company, today announced
it has entered into a definitive agreement (the "Agreement") to acquire HM Management Company Limited ("HM Management"),
a prominent AI agent production platform, in an all-stock transaction valued at approximately RMB300 million (US$41.7 million).
the Agreement, BGM will issue 16,663,427 Class A ordinary shares at $2.50 per share to acquire 100% ownership of HM Management and its
two wholly-owned subsidiaries: Beijing Shuda Technology Company Limited. ("Shuda Technology") and New Media Star Technology
(Shenzhen) Co., Ltd ( "New Media Star"). The transaction is expected to close in the second quarter of 2025, subject to customary
Technology is a high-tech company specializing in AI-driven enterprise efficiency solutions. By delivering integrated AI and data visualization
solutions, it empowers businesses to conduct intelligent, end-to-end diagnostics and enhance decision-making across the entire innovation
chain from research and development to commercialization, enabling rapid cost reduction, operational efficiency improvement, and business
model innovation. New Media Star operates a fast-growing AI tools platform with over 150,000 followers, offering proprietary and third-party
AI solutions for customer acquisition and private domain conversion.
Chen, Chief Executive Officer of the Company, stated: "The addition of Shuda Technology and New Media Start introduces a disruptive
engine to our strategy of building a multi-agentic production platform. Their matrix-based vertical industry agent cloning technology
and AI visualization engine address a critical strategic gap, enabling us to foster technological creativity and drive industry-wide impact.
This acquisition enhances our industry-specific AI DNA, allowing us to rapidly expand into vast market opportunities and create a leading
ecosystem of AI agent applications. Their portfolio of over 100 industry-specific AI modules, along with an established developer ecosystem,
will significantly accelerate our roadmap and secure a dominant position in the next-generation industry-specific AI operating systems."
acquisition expands the Company's AI application portfolio and further integrates existing market resources from its AI insurance and
AI mobility businesses, further solidifying the Company's position in the AI industry.
Group Ltd has a strategic focus on the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing,
and biopharmaceuticals.
terms of AI application implementation, the group relies on advanced analytics and AI Agent technology, and utilizes the two platforms
of Du Xiao Bao and Bao Wang to provide comprehensive and professional AI solutions and intelligent robot services for insurance companies,
insurance brokers, and consumers. Its services cover multiple key scenarios such as sales and marketing, underwriting assessment, claims
processing, and customer service. The group is capable of analyzing consumer data, building consumer profiles, accurately predicting insurance
needs, and providing highly customized services for consumers.
the field of biopharmaceuticals, the group's biopharmaceutical division mainly produces oxytetracycline API, crude heparin sodium, and
licorice preparations, which are widely supplied to the global animal husbandry, pharmaceutical, and drug retail markets. The group deeply
integrates AI-assisted decision-making into every link of production and manufacturing, achieving supply chain optimization, process efficiency
improvement, and market trend prediction. This provides scientific decision-making basis for the management and offers high-quality products
and precise services for consumers.
news release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended,
and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology
such as "will", "expects", "anticipates", "future", "intends", "plans", "believes",
"estimates", "target", "going forward", "outlook" and similar statements. Such statements are
based upon management's current expectations and current market and operating conditions and relate to events that involve known or unknown
risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's control, which
may cause the Company's actual results, performance or achievements to differ materially from those in the forward-looking statements.
Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities
and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information,
future events or otherwise, except as required under law.
investor and media inquiries, please contact: